Generics Bulletin
Alembic Remains Upbeat Despite Rhizen Setback
By Anju Ghangurde 17 May 2022
Disappointment for Alembic-backed Rhizen after partner TG Therapeutics takes Ukoniq off the US market amid wider regulatory scrutiny around the...
Industry analysts from Generics Bulletin are bringing you free insights from their comprehensive biosimilars coverage. Obtain critical industry information covering new biosimilars launches, company strategies, and new biosimilars product development.
Your free article pack from Generics Bulletin includes intelligence spanning a wide array of industry developments. Articles include:
Launches:
“Teva Sticks With 10% Discount For Trastuzumab”
Strategy:
“Stada Says Teriparatide Roll-Out Has Been Successful”
Product development:
“Revance Awaits Mylan Decision On Botox Biosimilar”
And many more
Your free article pack from Generics Bulletin includes intelligence spanning a wide array of industry developments. Articles include:
Regulations:
“FDA Overhauls Its Purple Book”
Litigation and Intellectual Property:
“Amgen Cleared Again On Kanjinti As Trial Looms”
Industry Interviews:
“Celltrion Healthcare Gears Up For Infliximab SC Launch”
And many more
Generics Bulletin
By Anju Ghangurde 17 May 2022
Disappointment for Alembic-backed Rhizen after partner TG Therapeutics takes Ukoniq off the US market amid wider regulatory scrutiny around the...
Generics Bulletin
By Dean Rudge 17 May 2022
Endo maintains that it will continue to drive revenue and EBITDA growth via business development opportunities, after the advent of...
Generics Bulletin
By David Wallace 17 May 2022
Japan’s Nippon Chemiphar and the International Finance Corporation have announced an alliance that will see the pair collaborate to boost...
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: